PEP-Therapy

Innovative peptides
as targeted therapies for oncology

LATEST NEWS

August 23rd, 2022

PEP-Therapy welcomes Ursula Vogel to its Board of Directors

+ READ MORE

October 5th, 2021

PEP-Therapy and Institut Curie announce first patients dosed in Phase I clinical trial of PEP-010 for the treatment of advanced solid tumors.

+ READ MORE

July 19th, 2021

PEP-Therapy extends Series-A financing, raising a total of €5.4 million to progress the clinical development of its lead candidate, PEP-010.

+ READ MORE